Live hepatocellular carcinoma updates

Live hepatocellular carcinoma news coverage of developments with the latest updates. Stay on top of latest hepatocellular carcinoma news stories and find out what just happened, what is going on with hepatocellular carcinoma. The latest real-time news updates and headlines on hepatocellular carcinoma
Machine learning models predict hepatocellular carcinoma treatment response
Researchers identify hormone from fat cells that reprogram liver microenvironment and restrain tumor growth in mice
Researchers identify hormone from fat cells that restrains tumor growth in mice
Synthetic ‘forever chemical’ linked to liver cancer
New technology in recent clinical study aims toward earlier detection of hepatocellular carcinoma
Liver Cancer’s Supercharged Metabolism Offers New Treatment Strategy, Penn Study Suggests
Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers Report
P53 in liver cancer
Blood test developed to predict liver cancer risk
Researchers develop blood test to predict liver cancer risk
New mechanism in CD47 blockade treatment in HCC
HKUMed discovers new metabolic route for liver cancer paving way for new therapeutic opportunities
New CMJ review presents noninvasive methods for better accuracy
How have hepatocellular carcinoma treatments improved?
Scientists discover new clues to liver cancer progression
Molecular profiling finds new high-risk subtype of pediatric liver cancer
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
New molecular subset of pediatric liver cancer identified
Seven out of ten patients with non-alcoholic fatty liver disease feel stigmatized
Study Sheds Light on Abnormal Lipidome Accumulation in Hepatocellular Carcinoma
Tremelimumab accepted under Priority Review in US for patients with unresectable liver cancer
CRISPR-Cas9 based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma
School of Medicine climbs ever closer to No. 1 NIH funding
MD Anderson research highlights for April 13, 2022
Globins – on hunt to protect your liver
Trialling non-invasive liver cancer treatment
AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma
Data from Codiak’s exoASO-STAT6 preclinical development program for treatment of primary and metastatic hepatic cancers published
Advancement in Hepatitis B cell lines step forward in discovering new treatments
Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells
Imfinzi plus tremelimumab demonstrated unprecedented survival in 1st-line unresectable liver cancer with 31% of patients alive
Researchers identify novel pathways responsible for liver cancer
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
ASTRO issues clinical guideline on external beam radiation therapy for primary liver cancers
Researchers Develop Optical Biopsy System that Detects Liver Cancer
HKUMed research team identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Research in primary liver cancer calls for novel strategies targeting dynamic landscape of heterogeneous tumors
CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy
Antiviral treatment for hepatitis C virus reduces risk of post-treatment liver cancer progression
Antitumoral effects of chemerin
Targeting Stem Cell Signaling Could Halt Liver Cancer Progression Elucidating novel therapeutic target
Target for Potential Cancer Drugs May, In Fact, Worsen Disease
New Curtin-led research aims to reduce stillbirth among Aboriginal families
Imfinzi plus tremelimumab significantly improved overall survival in HIMALAYA Phase III trial
MiRNA expression in cirrhosis and liver cancer
International experts develop Clinical Care Pathway in response to NASH epidemic
PSMA PET Imaging More Accurate Than CT in Detecting Hepatocellular Carcinoma
Unique sugar structures could identify early-stage liver cancer